Penumbra’s THUNDERBOLT Technology Gains CE Mark Certification for Stroke Management Advancement

- Penumbra's THUNDERBOLT technology receives CE Mark certification, enhancing acute ischemic stroke treatment in Europe and the U.S.
- THUNDERBOLT aims for rapid clot removal, addressing rising stroke mortality and improving treatment outcomes globally.
- Penumbra plans to bundle THUNDERBOLT with advanced catheters, emphasizing a holistic approach to patient care.
Penumbra (PEN) recently achieves CE Mark certification for its THUNDERBOLT technology, presenting a significant advancement in stroke management. This innovative device, which implements modulated aspiration techniques, is designed to enhance acute ischemic stroke treatment, a pressing issue given the escalating rates of stroke-related mortality. The World Health Organization has reported that deaths attributed to strokes are projected to rise by 50% between 2020 and 2050, underscoring the urgent need for effective solutions in this area. THUNDERBOLT’s ability to ensure rapid and complete clot removal aims to mitigate complications that arise from suboptimal treatments, signifying a much-needed evolution in stroke care.
CE Mark Certification and FDA Approval
With the CE Mark certification, the THUNDERBOLT technology now stands as an approved option for clinicians in Europe, complementing its recent approval from the U.S. FDA. Penumbra’s president, Shruthi Narayan, highlights the importance of this advancement, stating that THUNDERBOLT equips healthcare professionals with state-of-the-art tools to confront acute medical crises. The device is set to redefine standards in acute stroke care while reflecting Penumbra’s dedication to enhancing treatment protocols and outcomes for patients.
Integrating Innovative Solutions
As part of its comprehensive strategy, Penumbra plans to bundle the THUNDERBOLT device with advanced catheters from its product line, further emphasizing a holistic approach to patient care. This integration not only showcases the company's innovative capabilities but also reinforces its commitment to providing outstanding solutions for healthcare providers in over 100 countries.
A Leader in Thrombectomy Solutions
The launch of THUNDERBOLT symbolizes a broader push within the medical device industry to adopt and implement cutting-edge technologies that ultimately aim to improve patient outcomes and drive advancements in medical practices worldwide. Penumbra continues to solidify its role as a leader in thrombectomy solutions, consistently advocating for transformative changes in healthcare delivery.
Related Cashu News

Omnicell Appoints Dan Mandoli as Senior VP to Enhance Specialty Pharmacy Services Growth
Omnicell, Inc. (Ticker: OMCL) invests in its growth by appointing Dan Mandoli as Senior Vice President and General Manager of Specialty Pharmacy Services. With over 30 years of experience in pharmacy…

Insulet Advances Diabetes Management with Omnipod 6 and Upgrades Omnipod 5 Systems
Insulet Corporation (Ticker: PODD) announces significant advancements in diabetes management technology with the promising clinical data for its investigational Omnipod 6 system, designed to address t…

Neogen Expands Pest Control Products for Livestock in Texas and Florida to Enhance Animal Health
Neogen Corporation (Ticker: NEOG) enhances its product availability for livestock and horse owners in Texas and Florida. The company expands its FIFRA Section 2(ee) recommendations for the Prozap Inse…

Dexcom Advances Pediatric Diabetes Care with Stelo's OTC FDA Approval for Continuous Glucose Monitoring
In a significant advancement for diabetes management among children, Dexcom (Ticker: DXCM) continues to solidify its role in the continuous glucose monitoring (CGM) space. The recent FDA approval of S…